Curated dataset · n=51 verified deals · Not live market data · Scores are descriptive, not forecasts.

Network graph, deal flow, valuation matrix, and acquirer landscape.

Gynesonics→Hologic

Acquisition · Cash · HOLX · announced Sep 15, 2024

View in network
  1. Announced

    Sep 15, 2024

  2. Closed

    Oct 14, 2024

Economics

Cash()

Pre-deal · pre-deal mark: 2024, year precision · Hologic press release — acquisition announcement, 2024

~$350M (Hologic acquisition announcement)

Target

Gynesonics

Gynecological Surgery · Clinical / therapeutic

HQ Redwood City, CA · Founded 2005

Minimally invasive treatment for uterine fibroids (Sonata System for transcervical fibroid ablation)

  • Tracxn - Hologic acquisition list (Oct 14, 2024)
  • Gynesonics company website - gynesonics.com

Acquirer

Hologic (HOLX)

Breast Health

HQ Marlborough, MA

Why this buyer

Curated copy from the verified dataset — not an 8-K LLM summary

Minimally invasive uterine fibroid treatment — Sonata System complements Hologic's gynecological surgery portfolio

Evidence ladder

Press only — no primary filingValue disclosed
  1. Tertiary (trade / analyst)

    Tracxn acquisition records

  2. Tertiary (trade / analyst)

    Hologic investor relations (Oct 2024)

Limitations

  • Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
  • ~$350M (Hologic acquisition announcement)
  • Pre-deal valuation sourced from: Hologic press release — acquisition announcement, 2024. Pre-deal market-cap and funding citations do not corroborate the acquisition.

Valuation peers · Gynecological Surgery

Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.

TargetAcquirerAnnouncedValueWhy included
Bolder SurgicalHologicOct 14, 2021same evidence class · same acquirer
obp SurgicalCooperSurgical (CooperCompanies)Aug 1, 2024same evidence class

Other verified deals by Hologic

Acquirer program history not already listed as a valuation peer or adjacency row.

TargetAcquirerAnnouncedValueSector
EndomagneticsHologicMay 20, 2024Breast Health
BiotheranosticsHologicJan 5, 2021Breast Health
Acessa HealthHologicAug 25, 2020Gynecological Surgery
SuperSonic ImagineHologicJun 21, 2019Breast Health
Focal TherapeuticsHologicSep 26, 2018Breast Health

Patient empowerment context

Patient empowerment baseline (HLTH 2022)

No curated mapping — Gynesonics (Gynecological Surgery). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.

Research workspace (includes heuristic crosswalk) →

Related verified workspaces

Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.

Curated verified dataset v9 · updated 2026-09-20 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.